Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Chubb
Harvard Business School
QuintilesIMS
Julphar
Boehringer Ingelheim

Generated: May 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,720,314

« Back to Dashboard

Summary for Patent: 6,720,314
Title: Use of a vital dye for facilitating surgical procedures for cataract extraction
Abstract:Methods for performing a capsulorhexis are disclosed wherein a dye is used to stain a lens capsule of an eye. The dye is capable of staining tissue without diffusing through the tissue. Compositions including dyes that are useful in the methods are also disclosed.
Inventor(s): Melles; Gerrit Reinold J. (3071 MJ Rotterdam, NL)
Assignee:
Application Number:09/708,386
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 6,720,314
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form;

Drugs Protected by US Patent 6,720,314

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Dorc VISIONBLUE trypan blue SOLUTION;OPHTHALMIC 021670-001 Dec 16, 2004 RX Yes Yes ➤ Sign Up ➤ Sign Up A METHOD OF APPLYING TRYPAN BLUE ONTO AN OUTER SURFACE OF THE ANTERIOR LENS CAPSULE TO FACILITATE REMOVAL OF THE LENS SUBSTANCE ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,720,314

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
98201542May 8, 1998

International Family Members for US Patent 6,720,314

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 232400 ➤ Sign Up
Austria 234118 ➤ Sign Up
Australia 2003208122 ➤ Sign Up
Australia 3853699 ➤ Sign Up
Australia 3853799 ➤ Sign Up
Australia 757318 ➤ Sign Up
Australia 758951 ➤ Sign Up
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
McKinsey
Cipla
Chinese Patent Office
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.